News
Mineralys makes money moves before looming hypertension approval
1+ hour, 23+ min ago (57+ words) Endpoints News Min'eralys makes mon'ey moves be'fore loom'ing hy'per'ten'sion ap'proval Min'eralys Ther'a'peu'tics first drew at'ten'tion in 2021 with a bold bet on a new type of hy'per'ten'sion drug called lorun'dro'stat. It came with a tiny " Think we're worth reading - tell Google....
Lilly strikes Ascidian deal worth up to $1. 9 B for RNA editing in kidney diseases
4+ hour, 54+ min ago (66+ words) Endpoints News Lil'ly strikes As'cid'i'an deal worth up to $1. 9 B for RNA edit'ing in kid'ney dis'eases Last month, As'cid'i'an Ther'a'peu'tics pre'sent'ed the first da'ta sug'gest'ing a new way to fix bro'ken genes may be safe in peo'ple. Now " Think we're…...
Lilly gives hospitals deadline to comply with 340 B claims data policy
22+ hour, 5+ min ago (62+ words) Endpoints News Lil'ly gives hos'pi'tals dead'line to com'ply with 340 B claims da'ta pol'i'cy Eli Lil'ly is giv'ing a group of hos'pi'tals five days to com'ply with its new claims da'ta pol'i'cy or risk los'ing their 340 B dis'counts. Think we're worth…...
Anti-aging startup New Limit raises $435 M at $3 B+ valuation, eyes clinic in 2027
22+ hour, 20+ min ago (68+ words) Endpoints News An'ti-ag'ing start'up New Lim'it rais'es $435 M at $3 B+ val'u'a'tion, eyes clin'ic in 2027 The Bay Area start'up New Lim'it has closed one of biotech's largest pri'vate fi'nanc'ings of 2026 and ex'pects to start hu'man test'ing next year for its " Think…...
What's next for VEGF? ASCO offered clues, but answers will have to wait
23+ hour, 54+ min ago (69+ words) Endpoints News What's next for VEGF? AS'CO of'fered clues, but an'swers will have to wait CHICA'GO " Not long ago, there were hopes that a new class of can'cer drugs would re'peat the suc'cess of Keytru'da. In'stead, it seems more like'ly…...
Male contraception startup closes $92. 5 M Series B; Novartis bets on actinium in Phase 3
1+ day, 1+ hour ago (44+ words) Endpoints News Male con'tra'cep'tion start'up clos'es $92. 5 M Se'ries B; No'var'tis bets on ac'tini'um in Phase 3 Think we're worth reading - tell Google. Confirm Endpoints as a trusted biopharma news source...
Legend Biotech shares first in vivo CAR-T data, its next act after Carvykti
1+ day, 2+ hour ago (72+ words) Endpoints News Leg'end Biotech shares first in vi'vo CAR-T da'ta, its next act af'ter Carvyk'ti Leg'end Biotech's long-await'ed first show'ing of in vi'vo CAR-T da'ta is here, fu'el'ing mo'men'tum in the grow'ing field. Leg'end re'port'ed re'sults Tues'day on 12 lym'phoma " Think…...
Celcuity aims for broad FDA approval after positive breast cancer readout
1+ day, 3+ hour ago (64+ words) Endpoints News Cel'cu'ity aims for broad FDA ap'proval af'ter pos'i'tive breast can'cer read'out Cel'cu'ity said a com'bi'na'tion reg'i'men with its ex'per'i'men'tal drug geda'tolis'ib dou'bled pa'tients" like'li'hood of sur'vival with'out dis'ease pro'gres'sion or death in a late-stage breast can'cer " Think we're…...
Roche details narrow failure of breast cancer pill trial
1+ day, 3+ hour ago (58+ words) #ASCO26: Roche details narrow failure of breast cancer pill trial Endpoints News Roche de'tails nar'row fail'ure of breast can'cer pill tri'al Back in March, Roche re'vealed that the breast can'cer pill on which it had pinned bil'lion-dol'lar sales ex'pec'ta'tions had failed…...
Citing "dangerous deals," lawmakers propose China restrictions
1+ day, 3+ hour ago (65+ words) Exclusive: Bipartisan group of lawmakers unveil new bill to restrict China biotech Endpoints News Ex'clu'sive: Bi'par'ti'san group of law'mak'ers un'veil new bill to re'strict Chi'na biotech A bi'par'ti'san group of Michi'gan law'mak'ers re'leased a new bill that could great'ly sti'fle…...